RBC Capital Maintains Outperform on DRI Healthcare Trust, Raises Price Target to C$18
Portfolio Pulse from richadhand@benzinga.com
RBC Capital analyst Douglas Miehm has maintained an 'Outperform' rating on DRI Healthcare Trust and raised the price target from C$17 to C$18.
July 10, 2023 | 12:28 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
RBC Capital's 'Outperform' rating and raised price target for DRI Healthcare Trust could potentially boost investor confidence and positively impact the stock's price in the short term.
Analyst ratings and price targets can significantly influence investor sentiment and stock prices. In this case, RBC Capital's maintained 'Outperform' rating and raised price target for DRI Healthcare Trust indicates a positive outlook for the company, which could potentially lead to an increase in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100